Datwyler announced a collaboration with LTS Device Technologies, a developer of smart wearable devices for drug delivery, and Stevanato Group

Datwyler meets demand for injectable drug packaging components for COVID-19 vaccine providers. The company also pioneered its StarterPack™, a ready-to-use packaging system, that helps drug developers minimize time to market while putting quality first.

Datwyler, a leading provider of high-quality, system-critical elastomer components, was recognized by BioNTech among its partners in supporting the company to provide a vaccine for COVID-19. Datwyler is also a supplier to the Serum Institute of India. Since the onset of the coronavirus, Datwyler has supplied system-critical packaging components for injectable drugs such as stoppers and aluminum seals to vaccine developers around the world.

Over the past few months, Datwyler has been working tirelessly with industry leaders to develop sealing solutions for the multiple COVID-19 vaccine candidates and find ways to manufacture the projected demand for stoppers and aluminum seals. With projects already underway, Datwyler is preparing for increased capacity demands and rapid scale-up in our facilities all over the globe.

In these extraordinary times, Datwyler is working hard every day to support the global health environment, and is contributing to the fight against the COVID-19 world pandemic.